No Picture
News

Trianni, Inc. and San Diego Biomedical Research Institute Announce License Agreement for the Trianni Mouse®

SAN FRANCISCO and SAN DIEGO, March 21, 2019 /PRNewswire/ — Trianni, Inc. (“TRIANNI”) and San Diego Biomedical Research Institute (“SDBRI”) jointly announced today that they have entered into a license agreement for the use of the Trianni Mouse®, a … […]

No Picture
News

Biocept to Release 2018 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2019

SAN DIEGO, March 21, 2019 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing proprietary liquid biopsy tests that provide clinically actionable information to physicians to improve cancer tre… […]

No Picture
News

BioMed Realty Launches The Second Phase At Gateway of Pacific – Expanding Its Landmark Campus At The Front Door Of San Francisco’s Premier Life Science Market

BioMed Realty also closes a $430 million financing on the first phase of Gateway of Pacific after executing a long-term lease with AbbVie Inc. for 480,000 square feet

SAN DIEGO, March 20, 2019 /PRNewswire/ — BioMed Realty, a Blackstone portfolio co… […]

No Picture
News

Genomic Testing Associated with Significantly Lower Health Care Costs in High-Risk Breast Cancer Patients, According to Researchers from Duke University

New study in JNCCN finds 21-gene assay was associated with savings of approximately $3,600 per patient in chemotherapy costs alone for people with clinically high-risk breast cancer.

PLYMOUTH MEETING, Pa., March 19, 2019 /PRNewswire/ — New research … […]

No Picture
News

BioMed Realty Expands Life Science Footprint In San Francisco Bay Area With Campus Acquisition Of The Emeryville Center for Innovation

SAN DIEGO, March 18, 2019 /PRNewswire/ — BioMed Realty, a Blackstone portfolio company, announced today the acquisition of the Emeryville Center for Innovation, located in Emeryville, California, for approximately $135 million. This latest investme… […]

No Picture
News

Biocept Awarded Patent in Japan for the Capture of Rare Cells Including CTCs from Any Biological Sample of Interest with A Microchannel Device

Biocept expands intellectual property position to 32 issued patents globally for its highly sensitive methods for detecting cancer biomarkers in blood and other specimen types

SAN DIEGO, March 18, 2019 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a … […]